The Short Answer
FDA Pregnancy Category X drugs (isotretinoin, methotrexate, thalidomide) cause birth defects in 10–30% of exposed pregnancies and must be stopped 3–6 months before conception. Category D drugs (ACE inhibitors, some antidepressants) carry lower risk but require doctor review and possible switching [1].
Common Category X drugs include isotretinoin (acne), methotrexate (rheumatoid arthritis, cancer), finasteride (hair loss), and warfarin (blood clots). These cause cleft palate, heart defects, brain damage, and limb malformations. Category D drugs—ACE inhibitors, some antidepressants, NSAIDs—carry 2–5% birth defect risk but may be safer than stopping them abruptly. Your doctor must weigh the risk of the drug against the risk of untreated disease [1].
Teratogenic drugs harm the fetus by blocking cell division, disrupting hormone signaling, or poisoning developing organs. Isotretinoin causes severe facial, heart, and brain defects. Methotrexate blocks DNA synthesis and causes miscarriage and skeletal defects. ACE inhibitors lower blood pressure in the fetus and cause kidney damage and low amniotic fluid. The critical window is the first trimester, when organs form [1].
Start the medication review 6 months before trying to conceive. Your OB-GYN or primary care doctor can switch you to safer alternatives: for acne, use topical benzoyl peroxide; for arthritis, switch to sulfasalazine or certain biologics; for depression, many SSRIs are safe. If you're already pregnant and on a Category X drug, call your doctor immediately—don't stop abruptly, but get urgent guidance [1].
Try This Today
Bring all your medication bottles to your preconception visit—including over-the-counter pills, supplements, and topical creams. Ask your doctor: 'Is this safe for pregnancy, or do I need to switch?' Write down the answer and the switching timeline. This 10-minute conversation prevents 80% of medication-related birth defects.